Clinical Molecular Diagnosis of Wilson Disease

被引:42
作者
Bennett, James [2 ]
Hahn, Si Houn [1 ,2 ]
机构
[1] Univ Washington, Sch Med, Dept Pediat, Seattle Childrens Hosp,Div Genet Med, Seattle, WA 98105 USA
[2] Univ Washington, Sch Med, Div Med Genet, Dept Med, Seattle, WA 98105 USA
关键词
Wilson disease; genetic testing; molecular diagnosis; mutation spectrum; sensitivity; GENOTYPE-PHENOTYPE CORRELATION; COPPER TRANSPORTING ATPASE; MUTATION ANALYSIS; HIGH-FREQUENCY; ATP7B GENE; HAPLOTYPE ANALYSIS; HIGH PREVALENCE; IDENTIFICATION; POPULATION; SPECTRUM;
D O I
10.1055/s-0031-1286054
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Wilson disease is an autosomal recessive disorder of copper transport characterized by toxic accumulation of copper in the liver, brain, and other organs. It is lethal if untreated, but effective treatment is available. The broad spectrum of clinical manifestations, including hepatic and neuropsychiatric symptoms, can present over a large age range, contributing to difficulty in recognition of this disease. The diagnosis has traditionally rested on measurements of ceruloplasmin and copper in urine and liver, but it remains a challenge due to ambiguous biochemical results that can overlap with healthy carriers. Although hepatic copper concentration has been the gold standard for diagnosis, direct sequencing of the ATP7B gene is sensitive, specific, and can obviate the need for invasive liver biopsy. In this article, the authors review the sensitivity, limitations, and pitfalls of ATP7B sequencing in the diagnosis of Wilson disease. ATP7B sequencing should be standard practice in the diagnosis of Wilson disease.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 56 条
[11]   Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease [J].
Ferenci, P ;
Steindl-Munda, P ;
Vogel, W ;
Jessner, W ;
Gschwantler, M ;
Stauber, R ;
Datz, C ;
Hackl, F ;
Wrba, F ;
Bauer, P ;
Lorenz, O .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (08) :811-818
[12]   Diagnosis and phenotypic classification of Wilson disease [J].
Ferenci, P ;
Caca, K ;
Loudianos, G ;
Mieli-Vergani, G ;
Tanner, S ;
Sternlieb, I ;
Schilsky, M ;
Cox, D ;
Berr, F .
LIVER INTERNATIONAL, 2003, 23 (03) :139-142
[13]  
FIGUS A, 1995, AM J HUM GENET, V57, P1318
[14]   High prevalence of the very rare Wilson disease gene mutation Leu708Pro in the Island of Gran Canaria (Canary islands, Spain):: A genetic and clinical study [J].
García-Villarreal, L ;
Daniels, S ;
Shaw, SH ;
Cotton, D ;
Galvin, M ;
Geskes, J ;
Bauer, P ;
Sierra-Hernández, A ;
Buckler, A ;
Tugores, A .
HEPATOLOGY, 2000, 32 (06) :1329-1336
[15]   Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients [J].
Gupta, A ;
Aikath, D ;
Neogi, R ;
Datta, S ;
Basu, K ;
Maity, B ;
Trivedi, R ;
Ray, J ;
Das, SK ;
Gangopadhyay, PK ;
Ray, K .
HUMAN GENETICS, 2005, 118 (01) :49-57
[16]   Genotype-Phenotype Correlation in Wilson Disease [J].
Horslen, Simon ;
Hahn, Si Houn .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (06) :387-388
[17]  
Kalinsky H, 1998, HUM MUTAT, V11, P145, DOI 10.1002/(SICI)1098-1004(1998)11:2<145::AID-HUMU7>3.3.CO
[18]  
2-F
[19]   Sequence variation database for the Wilson disease copper transporter, ATP7B [J].
Kenney, Susan M. ;
Cox, Diane W. .
HUMAN MUTATION, 2007, 28 (12) :1171-1177
[20]  
Kim EK, 1998, HUM MUTAT, V11, P275, DOI 10.1002/(SICI)1098-1004(1998)11:4<275::AID-HUMU4>3.3.CO